Thioredoxin-like protein 2 is overexpressed in colon cancer and promotes cancer cell metastasis by interaction with ran.

AIMS Our previous work identified thioredoxin-like protein 2 (Txl-2) as the target of the monoclonal antibody MC3 associated with colon cancer, but its underlying mechanisms remain poorly understood. Txl-2, a novel thioredoxin (Trx) and nucleoside diphosphate kinase family member, is alternatively spliced and gives rise to three different Txl-2 isoforms. In this study, Txl-2 expression in colon cancer, differential functions for Txl-2 isoforms in cell invasion and metastasis, and the downstream signaling were investigated. RESULTS Txl-2 expression was elevated in colon cancer tissues compared to normal colonic tissues, with a high correlation between the histological grade and prognosis. Knockdown of Txl-2 expression significantly inhibited cancer cell motility, and the invasive and metastatic abilities of colon cancer cells. Interestingly, Txl-2 isoforms showed differential effects on cancer cell invasion and metastasis. Cell invasion and metastasis were significantly promoted by Txl-2b but inhibited by Txl-2c, while no obvious effect was observed for Txl-2a. Furthermore, a direct interaction was identified between Txl-2b and Ran, a Ras-related protein, by yeast two-hybrid assay and coimmunoprecipitation. PI3K pathway was found to be a major pathway mediating Txl-2b induced tumor invasion and metastasis. INNOVATION The current study provides a novel biomarker and target molecule for the diagnosis and treatment of colon cancer and provides a novel paradigm to understand how alternative splicing functions in human cancer. CONCLUSION Our findings demonstrate an elevated Txl-2 expression in colon cancer and that Txl-2b promotes cell invasion and metastasis through interaction with Ran and PI3K signaling pathway.

[1]  D. Fan,et al.  High Ran level is correlated with poor prognosis in patients with colorectal cancer , 2013, International Journal of Clinical Oncology.

[2]  Danyi Wen,et al.  Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells , 2012, The FEBS journal.

[3]  I. Chu,et al.  Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma , 2011, Experimental & Molecular Medicine.

[4]  B. Christensen,et al.  C-terminal Modification of Osteopontin Inhibits Interaction with the αVβ3-Integrin* , 2011, The Journal of Biological Chemistry.

[5]  E. Gramoustianou,et al.  Survivin isoform expression patterns in CML patients correlate with resistance to imatinib and progression, but do not trigger cytolytic responses. , 2011, Clinical immunology.

[6]  Chonghui Cheng,et al.  CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. , 2011, The Journal of clinical investigation.

[7]  J. Heo.  Redox control of GTPases: from molecular mechanisms to functional significance in health and disease. , 2011, Antioxidants & redox signaling.

[8]  Adrian V. Lee,et al.  Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling. , 2011, The Journal of clinical investigation.

[9]  C. Gialeli,et al.  Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting , 2011, The FEBS journal.

[10]  Li Yan,et al.  The significance of CD14+ monocytes in peripheral blood stem cells for the treatment of rat liver cirrhosis. , 2010, Cytotherapy.

[11]  A. Mes-Masson,et al.  An essential role for Ran GTPase in epithelial ovarian cancer cell survival , 2010, Molecular Cancer.

[12]  J. Shlomai.  Redox control of protein-DNA interactions: from molecular mechanisms to significance in signal transduction, gene expression, and DNA replication. , 2010, Antioxidants & redox signaling.

[13]  E. Harlow,et al.  Nucleoside diphosphate kinase Nm23-H1 regulates chromosomal stability by activating the GTPase dynamin during cytokinesis , 2010, Proceedings of the National Academy of Sciences.

[14]  Filip Lardon,et al.  A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. , 2010, The oncologist.

[15]  Xu Peng,et al.  Activation of the Ran GTPase Is Subject to Growth Factor Regulation and Can Give Rise to Cellular Transformation* , 2009, The Journal of Biological Chemistry.

[16]  A. Jemal,et al.  Worldwide Variations in Colorectal Cancer , 2009, CA: a cancer journal for clinicians.

[17]  Amos Bairoch,et al.  PROSITE, a protein domain database for functional characterization and annotation , 2009, Nucleic Acids Res..

[18]  A. Gartner,et al.  The NM23 family in development , 2009, Molecular and Cellular Biochemistry.

[19]  I. Lascu,et al.  The mammalian Nm23/NDPK family: from metastasis control to cilia movement , 2009, Molecular and Cellular Biochemistry.

[20]  Y. Ono,et al.  Role of nm23 in the regulation of cell shape and migration via Rho family GTPase signals , 2009, Molecular and Cellular Biochemistry.

[21]  Alan Hall,et al.  The cytoskeleton and cancer , 2009, Cancer and Metastasis Reviews.

[22]  P. Johnston,et al.  RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin , 2008, Oncogene.

[23]  J. Heo.  Redox regulation of Ran GTPase. , 2008, Biochemical and biophysical research communications.

[24]  D. Fan,et al.  Identification and distribution of thioredoxin‐like 2 as the antigen for the monoclonal antibody MC3 specific to colorectal cancer , 2008, Proteomics.

[25]  T. Oyama,et al.  High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma , 2008, International journal of cancer.

[26]  P. Lavia,et al.  The GTPase Ran: regulation of cell life and potential roles in cell transformation. , 2008, Frontiers in bioscience : a journal and virtual library.

[27]  S. Miyagawa,et al.  Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer. , 2008, Human pathology.

[28]  Chuanshu Huang,et al.  The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention. , 2007, Current cancer drug targets.

[29]  Qinghua Zhou,et al.  Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK activity and motility-suppressive ability*: P2-035 , 2007, Biochemical and biophysical research communications.

[30]  M. Pajares,et al.  Alternative splicing: an emerging topic in molecular and clinical oncology. , 2007, The Lancet. Oncology.

[31]  G. Nilsonne,et al.  Quantification of alternative mRNA species and identification of thioredoxin reductase 1 isoforms in human tumor cells. , 2007, Differentiation; research in biological diversity.

[32]  C. Welter,et al.  Expression of the nm23 homologues nm23‐H4, nm23‐H6, and nm23‐H7 in human gastric and colon cancer , 2005, The Journal of pathology.

[33]  C. V. van Noorden,et al.  The role of gelatinases in colorectal cancer progression and metastasis. , 2004, Biochimica et biophysica acta.

[34]  M. Almgren,et al.  Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma. , 2004, Molecular cancer research : MCR.

[35]  H. Steinbrenner,et al.  Thioredoxin secreted upon ultraviolet A irradiation modulates activities of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in human dermal fibroblasts. , 2004, Archives of biochemistry and biophysics.

[36]  S. Chakraborti,et al.  Regulation of matrix metalloproteinases: An overview , 2003, Molecular and Cellular Biochemistry.

[37]  D. Morrison,et al.  Nm23-H1 Metastasis Suppressor Phosphorylation of Kinase Suppressor of Ras via a Histidine Protein Kinase Pathway* , 2002, The Journal of Biological Chemistry.

[38]  P. C. Chin,et al.  Akt Is a Downstream Target of NF-κB* , 2002, The Journal of Biological Chemistry.

[39]  Alfred Wittinghofer,et al.  Structural Basis for Guanine Nucleotide Exchange on Ran by the Regulator of Chromosome Condensation (RCC1) , 2001, Cell.

[40]  A. Holmgren,et al.  Thioredoxin alters the matrix metalloproteinase/tissue inhibitors of metalloproteinase balance and stimulates human SK-N-SH neuroblastoma cell invasion. , 2001, European journal of biochemistry.

[41]  C. Kahn,et al.  Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23. , 2001, Cancer research.

[42]  K. Zänker,et al.  Differences in the migration capacity of primary human colon carcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). , 1998, Cancer letters.

[43]  Yana Zhang,et al.  Cancer-testis antigens: the current status on antigen regulation and potential clinical use. , 2012, American journal of blood research.

[44]  A. Holmgren,et al.  Thioredoxin and related molecules--from biology to health and disease. , 2007, Antioxidants & redox signaling.

[45]  T. Kieselbach,et al.  Characterization of Human Thioredoxin-like 2 A NOVEL MICROTUBULE-BINDING THIOREDOXIN EXPRESSED PREDOMINANTLY IN THE CILIA OF LUNG AIRWAY EPITHELIUM AND SPERMATID MANCHETTE AND AXONEME*□S , 2003 .

[46]  P. C. Chin,et al.  Akt is a downstream target of NF-kappa B. , 2002, The Journal of biological chemistry.